查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1965917

血糖值監測試紙市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、最終用戶、地區和競爭格局分類，2021-2031年

Blood Glucose Test Strips Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End-User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球血糖試紙市場預計將從 2025 年的 84.6 億美元成長到 2031 年的 129.2 億美元，複合年成長率為 7.31%。

血糖測定器を用いて試薬により糖度を定量化するこれらの診断用消耗品は、世界の糖尿病の負担増大と慢性ケアを必要とする高齢化人口により需要が拡大しております。国際糖尿病連合のデータによれば、2024年時点で世界中に約5億8,900万人の成人が糖尿病を患っており、この膨大な患者層が消費を牽引しております。在居家醫療環境において血糖コントロールを維持し併發症を回避するためには、自己管理が依然として極めて重要であるためです。

市場概覽
預測期 2027-2031
市場規模：2025年 84.6億美元
市場規模：2031年 129.2億美元
複合年成長率：2026-2031年 7.31%
成長最快的細分市場 妊娠糖尿病
最大的市場 北美洲

然而，市場面臨著一個重大挑戰，消費者越來越傾向於使用無需頻繁且痛苦的指尖採血的連續血糖監測系統。這種技術轉變對傳統血糖試紙的銷售構成威脅，因為患者擴大採用能夠提供即時測量的感測器設備。因此，儘管糖尿病的整體盛行率持續上升，但這些先進替代方案的快速普及可能會阻礙傳統檢測耗材的收入成長。

市場促進因素

市場成長的主要驅動力是全球糖尿病盛行率的不斷上升。便利且頻繁的血糖監測方案對於有效控制疾病至關重要。隨著都市化和生活方式的改變加速了第2型糖尿病的發展，維持血糖控制所需的診斷檢測量也隨著患者數量的成長而相應增加。這一成長的關鍵因素在於識別出先前未確診的病例，這使得這些人立即成為檢測用品的積極消費者。根據國際糖尿病聯盟（IDF）於2025年4月發布的第11版《糖尿病地圖集》，目前全球約有2.52億成年人患有未確診的糖尿病，隨著篩檢措施的加強，這代表著一個巨大的潛在市場。

同時，居家自我管理的日益普及正在重新定義患者參與的方式，並推動對診斷耗材的需求。這種向預防醫學的轉變使患者能夠在醫療機構之外主動監測血糖值，從而降低急性併發症和延長住院時間的風險。便捷易用的檢測設備的普及也促進了這一趨勢，鼓勵患者定期檢測並持續購買試紙。強勁的市場表現也反映在主要企業的財務表現中。例如，羅氏公司於2025年1月發布的《2024年度報告》顯示，其核心診斷業務的銷售額成長了8%。國際糖尿病聯盟（IDF）也預測，到2025年，全球與糖尿病相關的醫療支出將達到1.015兆美元，凸顯了經濟高效的管理工具的重要性。

市場挑戰

持續血糖監測（CGM）系統的快速普及為傳統血糖試紙產業的發展帶來了巨大挑戰。與每次測量都需要使用專用試紙的標準血糖儀不同，CGM設備採用皮下感測器，可實現24小時即時血糖值監測，從根本上改變了診斷耗材的消費模式。隨著使用感測器的患者減少對頻繁指尖採血的依賴（試紙主要用於備用或偶爾校準），傳統製造商正面臨持續且不可逆轉的銷售量下滑，而這正是他們的主要收入來源。

近期的一些應用指標也印證了這種從傳統檢測方法轉向新型血糖監測技術的轉變。根據美國糖尿病協會的數據，到2024年，美國第1型糖尿病患者中，年輕患者使用持續血糖監測技術的比例將達到約47%，成年患者將達到約37%。這種向基於感測器的解決方案的顯著轉變表明，需要進行最密集血糖監測的用戶群體中，相當一部分正在放棄傳統的血糖試紙市場。因此，這些先進設備的普及限制了試紙市場的整體潛在規模，並有效地抵消了原本預期因全球糖尿病盛行率上升而帶來的收入成長。

市場趨勢

以價值為導向的綜合糖尿病管理服務的興起，正在從根本上改變收入結構，推動行業從一次性耗材銷售轉向全面的訂閱模式。製造商正日益將血糖試紙整合到包含遠端指導和數據分析的綜合套餐中，從而確保長期穩定的收入來源，降低價格下跌的風險。這種方法強調持續的護理互動而非一次性檢測，從而提高了患者的依從性。 DarioHealth 於 2025 年 3 月發布的「2024 年第四季及全年財務表現」報告證實了此模式的成功，報告顯示其 B2B2C 業務管道的經常性收入達到 560 萬美元，年成長 398%。

同時，隨著支付者和消費者將降低成本作為首要考慮因素，自有品牌和品牌專賣店的試紙正迅速佔據顯著的市場佔有率。由於醫療系統面臨糖尿病帶來的沉重經濟負擔，零售環境中高品質、低成本的非專利藥正在加速取代傳統的高階品牌。這一趨勢推動了專注於白牌生產的製造商的銷售成長，這些製造商能夠在保證準確性的前提下提供價格實惠的產品。這項業績體現在新康生物感測技術有限公司於2025年4月發布的《2024年度報告》中，這家領先的具成本效益生物感測技術製造商累計，其淨利潤為3.2629億元人民幣（同比成長14.73%）。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球血糖值監測試紙市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（厚電化學膜、薄電化學膜、光學條帶）
    • 依最終使用者（醫院、門診手術中心等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美血糖值監測試紙市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲血糖值監測試紙市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區血糖值監測試紙市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲血糖值監測試紙市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲血糖值監測試紙市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球血糖值監測試紙市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Abbott Laboratories, Inc
  • Dexcom, Inc
  • F. Hoffmann-La Roche AG
  • Medtronic plc
  • Ascensia Diabetes Care Holdings AG
  • Sinocare Inc
  • Nemaura Medical Inc
  • Nipro Corporation
  • ARKRAY, Inc
  • Senseonics Holdings, Inc
  • B. Braun Medical Inc
  • LifeScan Inc
  • Prodigy Diabetes Care LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20211

The Global Blood Glucose Test Strips Market is projected to expand from a valuation of USD 8.46 Billion in 2025 to USD 12.92 Billion by 2031, reflecting a CAGR of 7.31%. These diagnostic consumables, which utilize reagents to quantify sugar levels through glucometers, are seeing demand fueled by the intensifying global burden of diabetes and an aging population necessitating chronic care. Data from the International Diabetes Federation indicates that approximately 589 million adults were living with diabetes worldwide in 2024, a massive patient demographic that drives consumption as self-monitoring remains critical for maintaining glycemic control and averting complications within home healthcare environments.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 8.46 Billion
Market Size 2031USD 12.92 Billion
CAGR 2026-20317.31%
Fastest Growing SegmentGestational Diabetes
Largest MarketNorth America

However, the market faces a substantial obstacle in the form of growing consumer preference for Continuous Glucose Monitoring systems, which remove the necessity for frequent and painful finger-prick tests. This technological shift poses a risk to traditional strip sales volumes as patients increasingly adopt sensor-based devices that provide real-time metrics. Consequently, the rapid widespread adoption of these sophisticated alternatives has the potential to hinder the revenue growth of conventional testing supplies, even as the overall prevalence of diabetes continues to rise.

Market Driver

The primary catalyst propelling market growth is the escalating global prevalence of diabetes mellitus, which necessitates accessible and frequent glucose monitoring solutions for effective condition management. As urbanization and lifestyle shifts drive the incidence of Type 2 diabetes, the expanding patient pool creates a proportional rise in the diagnostic testing volume needed to sustain glycemic control. A significant driver of this expansion is the identification of previously undiagnosed cases, which immediately transforms individuals into active consumers of testing supplies; according to the 'IDF Diabetes Atlas 11th Edition' released by the International Diabetes Federation in April 2025, nearly 252 million adults globally are currently living with undiagnosed diabetes, representing a vast latent market segment as screening initiatives ramp up.

Concurrently, the increasing adoption of home-based self-monitoring is redefining patient engagement and upholding demand for diagnostic consumables. This pivot toward preventive healthcare empowers patients to actively track blood sugar levels outside of clinical environments, thereby lowering the risks of acute complications and long-term hospitalizations, a trend supported by the proliferation of user-friendly testing devices that encourage regular checks and recurring strip purchases. The market's robustness is reflected in the financial results of major industry players; for instance, Roche's 'Annual Report 2024', published in January 2025, noted an 8% sales increase in its Diagnostics Division's base business, while the International Diabetes Federation estimated in 2025 that diabetes accounted for USD 1.015 trillion in global health expenditure, underscoring the critical need for cost-effective management tools.

Market Challenge

The rapid expansion of Continuous Glucose Monitoring (CGM) systems presents a significant barrier to the growth of the traditional blood glucose test strips sector. In contrast to standard glucometers that demand a specific strip for each reading, CGM devices employ subcutaneous sensors to offer real-time, 24-hour glucose tracking, fundamentally shifting the diagnostic supply consumption model. As patients utilizing sensors reduce their reliance on frequent finger-prick testing-using strips primarily for backup or occasional calibration-the recurring sales volume that serves as the main revenue source for legacy manufacturers faces a direct and irreversible downturn.

Recent adoption metrics substantiate this displacement of conventional testing methods. Data from the American Diabetes Association indicates that in 2024, the utilization of continuous glucose monitoring technology rose to approximately 47% among youth and 37% among adults with type 1 diabetes in the United States. This significant migration toward sensor-based solutions suggests that a substantial fraction of the most intensive glucose monitoring users are departing the daily test strip market. Consequently, the widespread uptake of these advanced devices constrains the total addressable market for strips, effectively neutralizing potential revenue benefits that would otherwise stem from the rising global prevalence of diabetes.

Market Trends

The emergence of value-based bundled diabetes management services is fundamentally reshaping revenue mechanisms, transitioning the industry from transactional consumable sales to holistic subscription models. Manufacturers are increasingly incorporating test strips into comprehensive packages that feature remote coaching and data analytics, thereby securing long-term recurring revenue streams that are less vulnerable to price erosion. This approach improves patient adherence by emphasizing continuous care engagement over isolated testing, a model whose success is highlighted by DarioHealth's 'Fourth Quarter and Full Year 2024 Financial and Operating Results' from March 2025, which reported a 398% year-over-year surge in recurring revenues from its B2B2C business channel to USD 5.6 million.

Simultaneously, the proliferation of private label and store-brand test strips is securing significant market share as payers and consumers prioritize cost containment. With healthcare systems facing the heavy economic weight of diabetes, there is an accelerated migration toward high-quality, lower-cost generic alternatives that are displacing legacy premium brands in retail environments. This trend fuels volume growth for manufacturers focused on white-label production who deliver affordability without sacrificing accuracy, a performance reflected in Sinocare Inc.'s '2024 Annual Report' from April 2025; the company, a key producer of cost-effective biosensing technologies, announced a net income of CNY 326.29 million, representing a 14.73% increase over the previous year.

Key Market Players

  • Abbott Laboratories, Inc
  • Dexcom, Inc
  • F. Hoffmann-La Roche AG
  • Medtronic plc
  • Ascensia Diabetes Care Holdings AG
  • Sinocare Inc
  • Nemaura Medical Inc
  • Nipro Corporation
  • ARKRAY, Inc
  • Senseonics Holdings, Inc
  • B. Braun Medical Inc
  • LifeScan Inc
  • Prodigy Diabetes Care LLC

Report Scope

In this report, the Global Blood Glucose Test Strips Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Glucose Test Strips Market, By Type

  • Thick Film Electrochemical Films
  • Thin Film Electrochemical Films
  • Optical Strips

Blood Glucose Test Strips Market, By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Blood Glucose Test Strips Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Glucose Test Strips Market.

Available Customizations:

Global Blood Glucose Test Strips Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Glucose Test Strips Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Thick Film Electrochemical Films, Thin Film Electrochemical Films, Optical Strips)
    • 5.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Blood Glucose Test Strips Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End-User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood Glucose Test Strips Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End-User
    • 6.3.2. Canada Blood Glucose Test Strips Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End-User
    • 6.3.3. Mexico Blood Glucose Test Strips Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End-User

7. Europe Blood Glucose Test Strips Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End-User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Blood Glucose Test Strips Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End-User
    • 7.3.2. France Blood Glucose Test Strips Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End-User
    • 7.3.3. United Kingdom Blood Glucose Test Strips Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End-User
    • 7.3.4. Italy Blood Glucose Test Strips Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End-User
    • 7.3.5. Spain Blood Glucose Test Strips Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End-User

8. Asia Pacific Blood Glucose Test Strips Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End-User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Blood Glucose Test Strips Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End-User
    • 8.3.2. India Blood Glucose Test Strips Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End-User
    • 8.3.3. Japan Blood Glucose Test Strips Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End-User
    • 8.3.4. South Korea Blood Glucose Test Strips Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End-User
    • 8.3.5. Australia Blood Glucose Test Strips Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End-User

9. Middle East & Africa Blood Glucose Test Strips Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End-User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Blood Glucose Test Strips Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End-User
    • 9.3.2. UAE Blood Glucose Test Strips Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End-User
    • 9.3.3. South Africa Blood Glucose Test Strips Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End-User

10. South America Blood Glucose Test Strips Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End-User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Blood Glucose Test Strips Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End-User
    • 10.3.2. Colombia Blood Glucose Test Strips Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End-User
    • 10.3.3. Argentina Blood Glucose Test Strips Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Blood Glucose Test Strips Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories, Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Dexcom, Inc
  • 15.3. F. Hoffmann-La Roche AG
  • 15.4. Medtronic plc
  • 15.5. Ascensia Diabetes Care Holdings AG
  • 15.6. Sinocare Inc
  • 15.7. Nemaura Medical Inc
  • 15.8. Nipro Corporation
  • 15.9. ARKRAY, Inc
  • 15.10. Senseonics Holdings, Inc
  • 15.11. B. Braun Medical Inc
  • 15.12. LifeScan Inc
  • 15.13. Prodigy Diabetes Care LLC

16. Strategic Recommendations

17. About Us & Disclaimer